1208694007: Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing peroxisome proliferator-activated receptor agonist (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Medicinal product categorized by disposition (product)\Product containing peroxisome proliferator-activated receptor agonist (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone (medicinal product)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Medicinal product categorized by disposition (product)\Product containing peroxisome proliferator-activated receptor agonist (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing pioglitazone in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Medicinal product categorized by disposition (product)\Product containing peroxisome proliferator-activated gamma receptor agonist (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Medicinal product categorized by disposition (product)\Product containing peroxisome proliferator-activated gamma receptor agonist (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone (medicinal product)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Medicinal product categorized by disposition (product)\Product containing peroxisome proliferator-activated gamma receptor agonist (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing pioglitazone in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing hydrolase inhibitor (product)\Product containing peptide hydrolase inhibitor (product)\Product containing dipeptidyl peptidase IV inhibitor (product)\Product containing alogliptin (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing hydrolase inhibitor (product)\Product containing peptide hydrolase inhibitor (product)\Product containing dipeptidyl peptidase IV inhibitor (product)\Product containing alogliptin (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone (medicinal product)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing hydrolase inhibitor (product)\Product containing peptide hydrolase inhibitor (product)\Product containing dipeptidyl peptidase IV inhibitor (product)\Product containing alogliptin (medicinal product)\Product containing alogliptin in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing alogliptin (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing alogliptin (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone (medicinal product)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing alogliptin (medicinal product)\Product containing alogliptin in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone (medicinal product)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole (product)\Product containing thiazolidinedione (product)\Product containing pioglitazone (medicinal product)\Product containing pioglitazone in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet

\Product manufactured as oral dose form (product)\Product containing pioglitazone in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
\Product manufactured as oral dose form (product)\Product containing alogliptin in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Alogliptin and pioglitazone only product in oral dose form\Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4970527014 Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4970528016 Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	Is a	Alogliptin and pioglitazone only product in oral dose form	true	Inferred relationship	Some
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	Has manufactured dose form	Oral tablet	true	Inferred relationship	Some
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	Has unit of presentation	Tablet (unit of presentation)	true	Inferred relationship	Some
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Pioglitazone hydrochloride	true	Inferred relationship	Some	1
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Pioglitazone (substance)	true	Inferred relationship	Some	1
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	1
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	1
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Alogliptin benzoate (substance)	true	Inferred relationship	Some	2
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Alogliptin	true	Inferred relationship	Some	2
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	2
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
4970527014	Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4970528016	Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core